What Is Hepatobiliary Surgery and What Does It Treat?

Hepatobiliary surgery is the surgical specialty focused on the liver, gallbladder, bile ducts, and pancreas. Surgeons in this field treat conditions ranging from liver cancer and bile duct tumors to gallstones lodged deep in the biliary system and traumatic injuries to these organs. Because the liver has an unusual ability to regenerate and because the bile duct system is an intricate network of tiny channels, the operations involved can be remarkably complex, often requiring preoperative planning techniques and intraoperative tools that don’t exist in most other branches of surgery.

The Organs Involved and Why They Need Their Own Specialty

The “hepato-” in hepatobiliary refers to the liver, and “biliary” refers to the bile ducts and gallbladder. Many hepatobiliary surgical units also handle the pancreas, since it shares drainage anatomy with the bile ducts. The liver performs hundreds of metabolic tasks, from filtering toxins to producing bile and clotting factors. Bile flows from the liver through a branching duct system into the gallbladder for storage, then into the small intestine to help digest fats. The pancreas sits right next door, emptying its digestive enzymes into the same stretch of intestine through a shared opening. When disease strikes any of these organs, the tight anatomical relationships mean that a tumor in the bile duct can obstruct the liver, a pancreatic mass can block bile flow, and surgery on one structure can inadvertently damage another. That interconnectedness is a big reason a dedicated surgical specialty exists.

The modern understanding of how to safely cut into the liver traces back to the 1950s, when Claude Couinaud published landmark studies showing that the liver is divided into functionally independent segments, each with its own blood supply and bile drainage. That insight transformed liver surgery from a high-risk gamble into a procedure that could be planned segment by segment.

Liver Cancer

Hepatocellular carcinoma, the most common primary liver cancer, is one of the leading reasons patients end up in a hepatobiliary operating room. Surgeons can remove the portion of the liver containing the tumor while leaving enough healthy tissue behind for the organ to regenerate. The catch is that many patients with liver cancer also have underlying liver scarring, or cirrhosis, which limits how much liver can safely be removed and worsens long-term outcomes. A study comparing patients with and without cirrhosis found that those with cirrhosis had significantly lower recurrence-free and overall survival after surgery, and that cirrhosis was an independent risk factor for worse prognosis, particularly in earlier-stage disease.¹ In a European series, patients with well-preserved liver function had an in-hospital mortality rate under 5%, compared to more than 20% in those with more advanced liver disease.² Factors like tumor size under 5 cm, complete removal of the cancer, and the absence of vascular invasion all independently predicted better long-term survival in that study.

Hepatobiliary surgeons also operate on cancers that started somewhere else and spread to the liver. The most common scenario is colorectal cancer metastases. Without surgery, survival with liver metastases from colorectal cancer is poor. With surgical removal, five-year survival rates can reach up to 58% in well-selected patients.³ A single-center study reported estimated one-, three-, and five-year overall survival rates of 91%, 56%, and 42% after liver metastasectomy.⁴ When the liver metastases are found at the same time as the original bowel cancer, surgeons have to decide whether to remove the bowel tumor first, tackle the liver first, or do both at once. Research comparing these strategies has found that the approach used doesn’t significantly change short- or long-term outcomes, but certain patient factors like persistent high tumor marker levels before surgery and the absence of post-surgical chemotherapy are associated with limited survival regardless of the sequence chosen.⁵

Bile Duct Cancers

Cholangiocarcinoma, or bile duct cancer, is less well known than liver cancer but can be even more surgically demanding. Tumors at the junction where the right and left bile ducts meet, known as hilar cholangiocarcinoma, often require removal of a large portion of the liver along with the bile duct and reconstruction of the biliary drainage. The goal is to get a clear margin, meaning no cancer cells at the cut edge. When the initial margin is positive, additional resection to achieve a negative margin can offer a survival benefit comparable to having a negative margin in the first place.⁶ That finding underscores why these operations are done at experienced centers where surgeons can assess margins in real time and extend the resection if needed.

For intrahepatic cholangiocarcinoma, a cancer arising within the liver’s bile duct branches, having your case discussed by an expert multidisciplinary team makes a measurable difference. A study of patients with this cancer found that those whose cases were discussed at an expert center had a median overall survival of about eight months, compared with roughly two and a half months for those who were not discussed by an expert team. Even after adjusting for disease severity, expert team discussion was independently associated with improved survival.⁷ That gap is striking and reflects the fact that specialist teams are more likely to identify candidates for surgery, optimize treatment sequencing, and apply combination strategies that community hospitals may not offer.

Gallstones and Bile Duct Stones

Most people associate gallbladder surgery with the straightforward laparoscopic cholecystectomy that millions of patients undergo each year. That procedure is common general surgery. Hepatobiliary surgery enters the picture when stones migrate from the gallbladder into the common bile duct, a condition called choledocholithiasis, which can cause jaundice, infection, or pancreatitis. The preferred first-line treatment is endoscopic removal during a procedure called ERCP, which is considered the gold standard and achieves excellent results with low complication rates.⁸

Management depends on when the stones are detected, how large the bile duct is, and what expertise is locally available. When possible, a one-step approach combining gallbladder removal with stone extraction during the same procedure is preferred.⁹ But some stones are too large, too numerous, or too awkwardly positioned for the endoscope to handle. In those cases, surgical extraction through an incision in the bile duct or even construction of a new connection between the bile duct and the intestine becomes necessary. These surgical alternatives carry low short- and long-term complication rates and serve as effective backups when endoscopy fails.⁸

Bridging Therapy and Downstaging Before Surgery

Not every liver tumor is operable at the time of diagnosis. Some are too large, too numerous, or positioned so that removing them would leave too little healthy liver behind. Hepatobiliary teams use several strategies to convert initially unresectable tumors into operable ones.

One technique is portal vein embolization, where interventional radiologists deliberately block the branch of the portal vein feeding the side of the liver that will be removed. This redirects blood flow to the side that will remain, causing it to grow over several weeks until it is large enough to sustain the patient after surgery.¹⁰ Portal vein embolization is now considered the standard of care for patients whose projected remaining liver volume is inadequate.¹¹

For hepatocellular carcinoma specifically, another approach involves using transarterial chemoembolization (TACE) to shrink tumors that can’t initially be removed. Once the tumor responds and shrinks, the patient may then undergo surgical resection or thermal ablation. A comparison of these two follow-up options after successful TACE downstaging found that five-year overall survival was about 83% in the surgery group and 75% in the ablation group, with no statistically significant difference between them.¹² That finding is reassuring because it means patients who can’t tolerate a major operation after downstaging still have a viable alternative.

Robotic and Minimally Invasive Liver Surgery

Open surgery, where a large incision is made across the abdomen, was once the only option for liver resection. Laparoscopic techniques using small incisions and a camera arrived later, and robotic platforms are now adding another option. The evidence comparing these approaches is evolving quickly.

A systematic review and network meta-analysis found that both robotic and laparoscopic liver resection resulted in shorter hospital stays and less post-surgical illness compared with open surgery. Laparoscopic surgery had the lowest readmission and liver-specific complication rates, while robotic surgery offered advantages in mortality and length of stay but at the highest total cost.¹³ Another network meta-analysis focusing specifically on hepatocellular carcinoma found that the robotic advantage was most pronounced for major resections, with a roughly two-thirds reduction in major complications compared with open surgery.¹⁴ That said, these results come from observational data, and the authors caution that unmeasured differences between patients chosen for each approach could skew the comparison.

For tumors in hard-to-reach locations like the upper-back segments of the liver, the robotic approach may be especially useful. A study comparing all three approaches for resections in these difficult segments found the robotic group had the shortest postoperative hospital stay at a median of four days, compared with six for laparoscopic and seven for open surgery, and had no major complications.¹⁵ Laparoscopic surgery had the shortest operative time and least blood loss in that comparison. The picture that emerges is that each approach has trade-offs, and the best choice depends on the tumor’s location, the extent of the resection, and the surgical team’s experience.

What Surgeons See During the Operation

One of the challenges of liver surgery is finding every tumor, especially small ones that imaging may have missed or lesions that are hidden deep within the organ. Hepatobiliary surgeons rely on several intraoperative tools to guide them. Intraoperative ultrasound has long been the standard, detecting about 92% of liver lesions in one study. Indocyanine green (ICG) fluorescence imaging, which uses a dye that glows under near-infrared light and concentrates in liver tumors, identified about 43% of lesions overall but was much better at finding superficial ones near the liver’s surface (about 95%) than deep ones (only about 4%).¹⁶

The real power seems to come from combining both tools. A meta-analysis found that using ultrasound and ICG fluorescence together achieved a sensitivity of over 99%, compared with roughly 92% for ultrasound alone and 87% for ICG fluorescence alone.¹⁷ ICG fluorescence also has value beyond just finding tumors. It can help surgeons visualize the boundaries of liver segments and guide the cutting plane during resection, acting as a kind of real-time map of the organ’s internal architecture.

Biliary Reconstruction

When a section of bile duct has been removed along with a tumor, or when the bile duct has been accidentally injured during gallbladder surgery, the remaining duct needs to be reconnected to the intestine so bile can flow again. The workhorse operation for this is Roux-en-Y hepaticojejunostomy, where a loop of small intestine is brought up and stitched directly to the cut end of the bile duct.¹⁸ This procedure is the principal method for repairing bile duct injuries and is considered the definitive treatment for many biliary conditions.

When performed at the right time and with proper technique, hepaticojejunostomy restores normal bile drainage in 80 to 90% of cases over the long term.¹⁹ Occasionally, strictures or stones can recur at the connection site, requiring a redo operation. Even repeated laparoscopic reconstruction has shown good feasibility, with no recurrence of narrowing or stone formation during follow-up in a reported series.²⁰ The timing of repair matters enormously. Operating on an inflamed, infected, or recently injured duct carries higher risks, so surgeons often wait weeks or months after the initial injury before attempting reconstruction.

What Happens After Surgery

Recovery from hepatobiliary surgery varies widely depending on the extent of the operation. A minor liver wedge resection may have you home in a few days. A major hepatectomy combined with bile duct reconstruction can mean a hospital stay of a week or more and a recovery period of several months.

One of the specific complications hepatobiliary surgeons watch for is bile leakage from the raw surface of the cut liver. The overall incidence of bile leakage after liver resection has been reported at roughly 3 to 9% and hasn’t changed much over recent decades despite advances in technique.²¹ Small leaks from less than one segment of the liver are typically managed without reoperation, using percutaneous drains or endoscopic stents. Larger leaks may require a return to the operating room.

Enhanced recovery after surgery (ERAS) protocols, which bundle evidence-based care steps like early eating, early walking, and optimized pain management, have made a significant difference in hepatobiliary outcomes. A retrospective study found that patients with high compliance to an ERAS protocol had a complication rate of 51% compared with about 70% in those with lower compliance, and their average hospital stay was more than three days shorter.²² Early ambulation, specifically getting up and walking within the first day after surgery, appears to be an especially important component. Patients who didn’t comply with early walking had hospital stays averaging nearly 12 days versus about 7.5 days for those who did, along with significantly higher rates of lung complications and 30-day readmissions.²³ Pain and fatigue are the main barriers to getting patients moving, which is why modern protocols put so much emphasis on non-opioid pain control strategies and early mobilization support.

Hepatobiliary Surgery in Children

Adults account for the vast majority of hepatobiliary operations, but children occasionally need them too. Choledochal cysts, which are abnormal dilations of the bile ducts present from birth, are a classic pediatric indication. The standard treatment is surgical removal of the cyst followed by reconstruction of the bile drainage, usually with a Roux-en-Y connection between the remaining bile duct and the intestine. When the duct at the hilum of the liver is unusually narrow, surgeons have adapted the Kasai procedure, originally developed for biliary atresia, to create a wide enough opening for bile to drain freely.²⁴ Biliary atresia itself, a condition in which a newborn’s bile ducts fail to develop properly, is perhaps the most urgent pediatric hepatobiliary problem and remains the leading indication for liver transplantation in children worldwide.

Pediatric liver tumors, including hepatoblastoma, are another domain. These cases are rare enough that most children’s hospitals see only a handful per year, making referral to specialized centers with hepatobiliary expertise essential. The surgical principles mirror adult practice in many ways, with an emphasis on achieving clear margins while preserving as much functional liver as possible, but the smaller anatomy and the need for growth-preserving approaches add unique challenges.